BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36558976)

  • 21. Physicochemical and molecular modeling studies of cefixime-L-arginine-cyclodextrin ternary inclusion compounds.
    Jadhav P; Petkar B; Pore Y; Kulkarni A; Burade K
    Carbohydr Polym; 2013 Nov; 98(2):1317-25. PubMed ID: 24053809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
    Ai F; Ma Y; Wang J; Li Y
    Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
    Jafar M; Khalid MS; Aldossari MFE; Amir M; Alshaer FI; Adrees FAA; Gilani SJ; Alshehri S; Hassan MZ; Imam SS
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1524-1534. PubMed ID: 32808552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component.
    Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S
    Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrospun formulation of acyclovir/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery.
    Celebioglu A; Uyar T
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111514. PubMed ID: 33255070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of amorphous ternary solid dispersions of dapagliflozin using PEG 6000 and Poloxamer 188: solid-state characterization,
    Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alshehri S; Elsaman T; Alomar FA; Akhtar S; Fahmy UA; Alhakamy NA; Alshammari MS
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1458-1467. PubMed ID: 32729728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.
    Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
    Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.
    García A; Priotti J; Codina AV; Vasconi MD; Quiroga AD; Hinrichsen LI; Leonardi D; Lamas MC
    Drug Deliv Transl Res; 2019 Feb; 9(1):273-283. PubMed ID: 30264285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of pioglitazone cyclodextrin inclusion complexes.
    Pandit V; Gorantla R; Devi K; Pai R; Sarasija S
    J Young Pharm; 2011 Oct; 3(4):267-74. PubMed ID: 22224032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
    Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
    J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.
    Dudhipala N; Ettireddy S; Youssef AAA; Puchchakayala G
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
    Giri BR; Lee J; Lim DY; Kim DW
    Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.